Abstract 4-Quinazolinones modified with 2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrole or 2,2,6,6-tetramethyl-1,2,3,6-tetrahydropyridine rings and their N-oxyl derivatives were synthesized and some of them evaluated for protecting activity against H 2 O 2 induced cell death on WRL-68 human liver cell line. Compounds 15a, 15c and 15d exhibited remarkably inhibitory effects on PARP enzyme in vitro.
Introduction
Poly(ADP-ribose) polymerase is an abundant eucariotic nuclear zinc-finger DNA-binding protein with a role of genomic repair.
1,2 DNA strand breaks generated either directly by genotoxic agents (alkylating agents, reactive oxygen species (ROS), ionizing radiation) or indirectly, following enzymatic incision of a DNA-base lesion, activate PARP enzyme. PARP catalyzes the biochemical conversion of the respiratory coenzyme, nicotinamide dinucleotide (NAD) to poly(ADP-ribose) and nicotinamide, therefore the latter is a weak feedback inhibitor of this enzyme. Although PARP has an important role in genomic repair mechanism, the massive activation of PARP results in extended ADP ribosylation and depletion of NAD. In the next step this leads to ATP depletion in an effort to resynthesize NAD and ultimately the lack of ATP and NAD causes mitochondrial dysfunction and cell death. The first PARP inhibitors were based on mimicking the structure of nicotinamide and benzamide analogs. 3 Recent research aimed at synthesizing more potent and selective PARP inhibitors based on the crystal structure of the catalytic domain of PARP, leading to polycyclic amides and lactams. 4, 5 One of the most potent compounds evaluated recently is the 8-hydroxy-2-methylquinazolin-4(3H)-one (NU-1025, IC 50 = 400 nM). 6, 7 In our laboratory we have synthesized 4-quinazolinone derivative, H-2641 as an antiarrhythmic drug candidate. 8 It was a real challenge to test and compare this compound with basic quinazolines 1-3 ( Figure 1 ) on PARP inhibitory activity assay as well as synthesizing new quinazolinone derivatives attached to 1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrole or 1-oxyl-2,2,6,6-tetramethyl-1,2,3,6-tetrahydropyridine and their amine precursors, because these rings exhibited radical scavenging activity and protected against oxidative stress. This fact can be a significant contribution in designing new PARP inhibitors against cell damage induced by antiviral 11 and anticancer drugs. Application of anticancer and antiviral compounds in the therapy is also mostly inevitably complemented by ROS formation whose in statu nascendi scavenging may moderate further the side-effects of these drugs compared to regular PARP inhibitors. Unfortunately neither compound 8 nor 9 has significant PARP inhibitory activity (Table 1) in accordance with earlier reports showing that alkylation of lactam NH resulted in loss of PARP activity. 7 It was obvious that lactam must remain intact to get more active PARP inhibitors, so compound 3 was alkylated with five-membered (6) and six-membered (7) 16 paramagnetic allylic bromides to give compounds 10 and 12, respectively. The corresponding amino derivatives 11 and 13 were achieved by reduction of paramagnetic compounds with Fe powder in AcOH.
Results and Discussion
Compounds with amine side-chains were obtained by alkylation of compound 3 with similar, but more readily available amine derivatives such as 2-dimethylaminoethyl chloride 14a, 3-dimethylaminopropyl chloride 14b, 1-(2-chloroethyl)piperidine 14c and 2,2,6,6-tetramethyl-1-(2-chloroethyl)piperidine 14d 17 in DMF in the presence of 2 eq. K 2 CO 3 to afford compounds 15a-d, respectively (Scheme 2). Tertiary amines 15a, 15c and 15d exhibited better PARP inhibitory activity than secondary amines 11, 13 or their corresponding radicals 10, 12. Regarding the structure-activity relationship (SAR), the principal ring compound protecting activity greatly varied depending on the substituent. Compounds 1, 2 exhibited good activity, compound 3 exhibited limited activity, 4, 5 and H-2641 with cardioprotective activity 8 were inactive in PARP inhibitory assay. The ω-amino S-alkylated compounds 15a-d exhibited better protection activity than the S-ethyl one (4). The piperidine compounds 15c and 15d did not have any significant difference in activity, the preliminary toxicity was also similar. Among the dimethylamino containing side-chain compounds 15a exhibited better activity than 15b.
Compounds substituted on the lactam NH (8, H-2641) were inactive, while compound 9 exhibited some moderate activity. Quinazolinones substituted at the 2-position with tetrahydropyridine rings showed good activity, however the amino precursor 22 had slightly better activity than the corresponding N-oxyl derivative 21. The N-hydroxy salt of radical 19 was inactive (Table 1 and 2). In conclusion, series of 4(3H)-quinazolinone derivatives were synthesized by a convenient alkylation of 4(3H)-quinazolinones (2, 3) and acylation of anthranilonitrile followed by cyclisation. Among the synthesized and studied compounds 4(3H)-quinazolinone derivatives substituted at the 2-position with tertiary amines containing S-ethyl spacer were found to be effective PARP inhibitors. Nitroxides or its amino precursor has lower inhibitory activity than tertiary amines, however nitroxides and its amino precursor may have a potential advantage as a possible radical scavenger analogously to the previous results. 9, 10, 21 Experimental Section General Procedures. Melting points were determined with a Boetius micro melting point apparatus and are uncorrected. Elemental analyses (C, H, N, S) were performed on Fisons EA 1110 CHNS elemental analyser. The IR (Specord 75) spectra were in each case consistent with the assigned structure. Mass spectra were recorded on a VG TRIO-2 instrument in the EI mode. 1 ) was added. Incubation was continued for 3 more hours, the medium was removed, and the metabolically reduced water insoluble blue formasan dye was solubilised by acidic isopropanol. Optical densities were determined by an Anthos Labtech 2010 ELISA reader (Wien, Austria) at 550 nm wavelength. All experiments were run in at least 6 parallels and repeated 3 times. Data showed in Table 1 are the concentration in µM at which the rate of H 2 O 2 induced cell death is inhibited with 50 %.
Inhibitory effects of 4-quinazolinone derivatives on PARP enzyme in vitro
The poly-ADP-ribose polymerase was isolated from rat liver based on the method described before. 22, 23 The potential inhibitory effects of 4-quinazolinone derivatives were tested in this assay system. The PARP activity was determined in 130 µl reaction mixture contained 100 mM Tris-HCl buffer, pH 8.0, 10 mM MgCl 2 , 10 % glycerol, 1.5 mM DTT, 1 mM [Adenine-2,8-3 H] NAD + (4.500 cpm/nmol), 10 µg activated DNA and 10 µg histones. The incubation time was 15 minutes in the presence or in the absence of 4-quinazolinone derivatives, and the reaction was stopped by the addition of trichloroacetic acid (8 %). After addition of 0.5 mg albumin, precipitation was allowed to proceed for at least 20 minutes on ice, and the insoluble material was collected on a glass filter washed five times with 5 % perchloric acid. The protein-bound radioactivity was determined by a LS-200 Beckman scintillation counter, data showed in Table 2 are the concentration in µM.
3-[(1-Oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl]-2-methylquinazolin-4(3H)-one radical (8).
A solution of 2-methylquinazolin-4(3H)-one (2) (1.60 g, 10.0 mmol), allylic bromide (6) (2.33 g, 10.0 mmol) and K 2 CO 3 (1.38 g, 10.0 mmol) in DMF (15 mL) was stirred at 90 °C for 6 h. The solvent was evaporated, the residue was dissolved in CHCl 3 (30 mL), washed with brine (10 mL), the organic phase was separated, dried (MgSO 4 ), filtered, evaporated and the residue was purified by flash column chromatography (hexane/EtOAc) to give the title compound 1.77 g (57 %) as a yellow solid, mp 110-112 °C. Anal. calcd. for Oxyl-2,2,6,6-tetramethyl-1,2,3,6-tetrahydropyridin-4-yl) 2-[(2-Piperidin-1-ylethyl)thio]quinazolin-4(3H)-one (15c) Oxyl-2,2,6,6-tetramethyl-1,2,3,6 -tetrahydropyridine-4-yl)quinazolin-4(3H)-one radical (21). To a stirred solution of 2-amino-benzonitrile (1.18 g, 10.0 mmol) and Et 3 N (1.11 g, 11.0 mmol) in CH 2 Cl 2 (20 mL) freshly made compound 17 or 18 (10.0 mmol) in CH 2 Cl 2 (10 mL) was added dropwise at 0 °C, then the mixture was stirred further at rt. for 1 h. The organic phase was washed with aq. 10 % K 2 CO 3 (15 mL), aq. 5 % H 2 SO 4 (10 mL), brine (15 mL), the organic phase was separated, dried (MgSO 4 ), filtered, evaporated. The crude amide was dissolved in dioxane (40 mL) and water (40 mL). The mixture was heated to reflux and treated with NaBO 3 . 4H 2 O (4.6 g, 30.0 mmol) over 2 h and the mixture was refluxed till consumption of the amide (5 h). After cooling the solvents were evaporated under reduced pressure, the residue was dissolved in CHCl 3 (20 mL), washed with brine (10 mL), the organic phase was separated, dried (MgSO 4 ), filtered, evaporated and the residue was purified by flash column chromatography ( 2-(2,2,6,6-Tetramethyl-1,2,3,6 -tetrahydropyridine-4-yl)quinazolin-4(3H)-one (22 
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